Autopsy report · NCT04156880
Artificial Intelligence in Mammography-Based Breast Cancer Screening
Cause of deathStaffing, sites or logistics
“the collaborating party of AI system withdraw their study due to change of company policy in year of COVID-19 pandemic”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer
- Interventions
- mammography
- Participants
- 0
- Sites
- 1
- Countries
- Hong Kong
Trials that died the same way
- Smoking Reduction: Testing a Novel Approach to Cessation in Primary Care Practice Settings
“Funding was withdrawn in January 2020. Covid-19 pandemic prevented the study from continuing to a point where it would need to be restarted. Multiple participants dropped out throughout pandemic.” - Serratus Plane Block for Postoperative Pain Control
“We decided to terminate this study due to staffing changes and other limitations posed by the COVID-19 pandemic.” - Camp Based Multi-component Intervention for Families of Young Children With Type 1 Diabetes
“Study terminated due to COVID-19 pandemic” - TDCS-Augmented Prolonged Exposure Therapy
“Study withdrawn due to delay in recruitment due to COVID-19; the PI also moved to a new institution.” - Effects of Short-term Choir Participation on Auditory Perception in Hearing-aided Older Adults.
“COVID-19 forced the shut down of the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.